Form 8-K - Current report:
SEC Accession No. 0001193125-26-084251
Filing Date
2026-03-02
Accepted
2026-03-02 07:54:26
Documents
16
Period of Report
2026-02-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d110966d8k.htm   iXBRL 8-K 28216
2 EX-99.1 d110966dex991.htm EX-99.1 21692
7 GRAPHIC g110966dsp001.jpg GRAPHIC 24002
8 GRAPHIC g110966g0301015930182.jpg GRAPHIC 9954
  Complete submission text file 0001193125-26-084251.txt   255439

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20260228.xsd EX-101.SCH 3561
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20260228_def.xml EX-101.DEF 13649
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20260228_lab.xml EX-101.LAB 22988
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20260228_pre.xml EX-101.PRE 14923
18 EXTRACTED XBRL INSTANCE DOCUMENT d110966d8k_htm.xml XML 5922
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 26703522
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)